Nautilus Biotechnolgy
NAUT
56 hedge funds and large institutions have $380M invested in Nautilus Biotechnolgy in 2021 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 15 increasing their positions, 10 reducing their positions, and 12 closing their positions.
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
130% more capital invested
Capital invested by funds: $165M → $380M (+$214M)
100% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 12
50% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 10
27% more funds holding
Funds holding: 44 → 56 (+12)
18% more call options, than puts
Call options by funds: $294K | Put options by funds: $250K
46.2% less ownership
Funds ownership: 77.66% → 31.46% (-46%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$96.5M |
| 2 |
MVG
Madrona Venture Group
Seattle,
Washington
|
+$65.2M |
| 3 |
CFM
Comprehensive Financial Management
Los Gatos,
California
|
+$24.1M |
| 4 |
ABG
Ally Bridge Group
New York
|
+$16.2M |
| 5 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$16.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AWG
Alpha Wave Global
New York
|
-$8.39M |
| 2 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
-$7.78M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.77M |
| 4 |
ESCM
Echo Street Capital Management
New York
|
-$3.95M |
| 5 |
ACM
Altium Capital Management
New York
|
-$3.95M |
NAUT Hedge Fund Activity: Q2 2021 in Review
56 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Nautilus Biotechnolgy (NAUT) for Q2 2021, worth a combined $380M — up 130% from $165M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new NAUT positions and 12 closed out — a net gain of 12 holders — while 15 added to existing stakes and 10 trimmed.
The largest buyer was Perceptive Advisors, opening a new position worth an estimated $96.5M. The largest seller was Alpha Wave Global, exiting entirely with an estimated $8.39M sold.
- 56 institutional investors held Nautilus Biotechnolgy (NAUT) as of Q2 2021, up from 44 in Q1 2021.
- Funds reported $380M of Nautilus Biotechnolgy stock for Q2 2021, up 130% quarter-over-quarter.
- 24 funds opened new Nautilus Biotechnolgy positions in Q2 2021 and 12 closed out, a net change of +12 holders.
- The largest Nautilus Biotechnolgy buyer in Q2 2021 was Perceptive Advisors, an estimated $96.5M added.
- The largest Nautilus Biotechnolgy seller in Q2 2021 was Alpha Wave Global, an estimated $8.39M sold.
Based on aggregated 13F filings for Q2 2021.